Works in Diabetes, Obesity & Metabolism, 2022, Vol 24, Issue 2

Results: 24

Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 177, doi. 10.1111/dom.14599

By:

Fadini, Gian Paolo;
Del Prato, Stefano;
Avogaro, Angelo;
Solini, Anna

Publication type:

Article

Longitudinal audit of assessment and pharmaceutical intervention for cardiovascular risk in the Australasian Diabetes Data Network.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 354, doi. 10.1111/dom.14584

By:

Robertson, Claire A.;
Earnest, Arul;
Chee, Melissa;
Craig, Maria E.;
Colman, Peter;
Barrett, Helen L.;
Bergman, Philip;
Cameron, Fergus;
Davis, Elizabeth A.;
Donaghue, Kim C.;
Fegan, P. Gerry;
Hamblin, P. Shane;
Holmes–Walker, D. Jane;
Jefferies, Craig;
Johnson, Stephanie;
Mok, Meng T.;
King, Bruce R.;
Sinnott, Richard;
Ward, Glenn;
Wheeler, Benjamin J.

Publication type:

Article

Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: A randomized, open‐label, noninferiority trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 312, doi. 10.1111/dom.14583

By:

Cai, Meili;
Shao, Xiaowen;
Xing, Feng;
Zhang, Yuqin;
Gao, Xinyu;
Zeng, Qiongjing;
Dilimulati, Diliqingna;
Qu, Shen;
Zhang, Manna

Publication type:

Article

A model‐based simulation of glycaemic control and body weight when switching from semaglutide to 3.0‐ and 4.5‐mg doses of once‐weekly dulaglutide.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 302, doi. 10.1111/dom.14582

By:

Tham, Lai San;
Pantalone, Kevin M.;
Dungan, Kathleen;
Munir, Kashif;
Tang, Cheng Cai;
Konig, Manige;
Kwan, Anita Y. M.

Publication type:

Article

Patterns of insulin therapy and insulin daily doses in children and adolescents with type 1 diabetes in Germany.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 296, doi. 10.1111/dom.14581

By:

van den Boom, Louisa;
Kostev, Karel

Publication type:

Article

Cardiovascular risk profiles: A cross‐sectional study evaluating the generalizability of the glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN‐6 to the real‐world type 2 diabetes population in the United Kingdom

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 289, doi. 10.1111/dom.14580

By:

Webb, Joanne;
Mount, Julie;
von Arx, Lill‐Brith;
Rachman, Jonathan;
Spanopoulos, Dionysis;
Wood, Robert;
Tritton, Theo;
Massey, Olivia;
Idris, Iskandar

Publication type:

Article

Cardiovascular and microvascular outcomes with iGlarLixi versus iDegLira: A real‐world, population‐based cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 348, doi. 10.1111/dom.14579

By:

Cowart, Kevin;
Gonzalez, Rachel;
Carris, Nicholas W.

Publication type:

Article

The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 281, doi. 10.1111/dom.14578

By:

Zobel, Emilie H.;
von Scholten, Bernt Johan;
Hansen, Tine W.;
Persson, Frederik;
Rasmussen, Søren;
Wolthers, Benjamin;
Rossing, Peter

Publication type:

Article

Influenza vaccination and prognosis for COVID‐19 in hospitalized patients with diabetes: Results from the CORONADO study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 343, doi. 10.1111/dom.14577

By:

Diallo, Alhassane;
Pichelin, Matthieu;
Wargny, Matthieu;
Gourdy, Pierre;
Bonnet, Jean‐Baptiste;
Hadjadj, Samy;
Cariou, Bertrand;
Sultan, Ariane;
Galtier, Florence

Publication type:

Article

Vagal afferent cholecystokinin receptor activation is required for glucagon‐like peptide‐1–induced satiation.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 268, doi. 10.1111/dom.14575

By:

Vana, Vasiliki;
Lærke, Michelle K.;
Rehfeld, Jens F.;
Arnold, Myrtha;
Dmytriyeva, Oksana;
Langhans, Wolfgang;
Schwartz, Thue W.;
Hansen, Harald S.

Publication type:

Article

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 257, doi. 10.1111/dom.14574

By:

Pedersen‐Bjergaard, Ulrik;
Agesen, Rikke M.;
Brøsen, Julie M. B.;
Alibegovic, Amra C.;
Andersen, Henrik U.;
Beck‐Nielsen, Henning;
Gustenhoff, Peter;
Hansen, Troels K.;
Hedetoft, Christoffer;
Jensen, Tonny J.;
Juhl, Claus B.;
Jensen, Andreas K.;
Lerche, Susanne S.;
Nørgaard, Kirsten;
Parving, Hans‐Henrik;
Sørensen, Anne L.;
Tarnow, Lise;
Thorsteinsson, Birger

Publication type:

Article

Effects of dipeptidyl peptidase‐4 inhibitors and sulphonylureas on cognitive and physical function in nursing home residents.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 247, doi. 10.1111/dom.14573

By:

Zullo, Andrew R.;
Duprey, Matthew S.;
Smith, Robert J.;
Gutman, Roee;
Berry, Sarah D.;
Munshi, Medha N.;
Dore, David D.

Publication type:

Article

A phase 1 multiple‐ascending dose study of tirzepatide in Japanese participants with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 239, doi. 10.1111/dom.14572

By:

Furihata, Kenichi;
Mimura, Hanaka;
Urva, Shweta;
Oura, Tomonori;
Ohwaki, Kenji;
Imaoka, Takeshi

Publication type:

Article

Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 321, doi. 10.1111/dom.14571

By:

Yamada, Yuichiro;
Yabe, Daisuke;
Hertz, Christin Løth;
Horio, Hiroshi;
Nakamura, Jiro;
Nielsen, Anne Møller;
Seino, Yutaka

Publication type:

Article

Effects of sodium‐glucose cotransporter 2 inhibitors on serum uric acid in patients with type 2 diabetes mellitus: A systematic review and network meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 228, doi. 10.1111/dom.14570

By:

Hu, Xiaodong;
Yang, Yue;
Hu, Xiaona;
Jia, Xiaomeng;
Liu, Hongzhou;
Wei, Minjie;
Lyu, Zhaohui

Publication type:

Article

Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 221, doi. 10.1111/dom.14568

By:

Johansen, Nicklas J.;
Dejgaard, Thomas F.;
Lund, Asger;
Schlüntz, Camilla;
Hartmann, Bolette;
Holst, Jens J.;
Vilsbøll, Tina;
Andersen, Henrik U.;
Knop, Filip K.

Publication type:

Article

Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump‐treated type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 212, doi. 10.1111/dom.14567

By:

Schmidt, Signe;
Frandsen, Christian S.;
Dejgaard, Thomas F.;
Vistisen, Dorte;
Halldórsson, Thórhallur;
Olsen, Sjudur F.;
Jensen, Jens‐Erik B.;
Madsbad, Sten;
Andersen, Henrik U.;
Nørgaard, Kirsten

Publication type:

Article

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add‐on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA‐PRIME).

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 204, doi. 10.1111/dom.14566

By:

Unger, Jeff;
Allison, Dale C.;
Kaltoft, Margit;
Lakkole, Kavitha;
Panda, Jayant K.;
Ramesh, Chethana;
Sargin, Mehmet;
Smolyarchuk, Elena;
Twine, Melissa;
Wolthers, Benjamin;
Yarimbas, Gizem;
Zoghbi, Marouan

Publication type:

Article

Effects of glucagon‐like peptide‐1 receptor agonists on histopathological and secondary biomarkers of non‐alcoholic steatohepatitis: A systematic review and meta‐analysis.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 337, doi. 10.1111/dom.14565

By:

Borodavkin, Petr;
Sheridan, William;
Coelho, Claudia;
Oštarijaš, Eduard;
Zaïr, Zoulikha M.;
Miras, Alexander D.;
McGowan, Barbara;
le Roux, Carel W.;
Vincent, Royce P.;
Dimitriadis, Georgios K.

Publication type:

Article

Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 332, doi. 10.1111/dom.14564

By:

Pieber, Thomas R.;
Bajaj, Harpreet S.;
Heller, Simon R.;
Jia, Ting;
Khunti, Kamlesh;
Klonoff, David C.;
Ladelund, Steen;
Leiter, Lawrence A.;
Wagner, Lily;
Philis‐Tsimikas, Athena

Publication type:

Article

Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double‐blind meal test early‐phase study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 196, doi. 10.1111/dom.14563

By:

Kazda, Christof;
Leohr, Jennifer;
Liu, Rong;
Reddy, Shobha;
Dellva, Mary Anne;
Loh, Mei Teng;
Hardy, Thomas;
Plum‐Mörschel, Leona

Publication type:

Article

Ultra rapid lispro (URLi) shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early‐phase study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 187, doi. 10.1111/dom.14561

By:

Leohr, Jennifer;
Kazda, Christof;
Liu, Rong;
Reddy, Shobha;
Dellva, Mary Anne;
Matzopoulos, Mark;
Loh, Mei Teng;
Hardy, Thomas;
Klein, Oliver;
Kapitza, Christoph

Publication type:

Article

Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 327, doi. 10.1111/dom.14560

By:

Buzzetti, Raffaella;
Bonadonna, Riccardo C.;
Giaccari, Andrea;
Perseghin, Gianluca;
Cucinotta, Domenico;
Fanelli, Carmine;
Avogaro, Angelo;
Aimaretti, Gianluca;
Larosa, Monica;
Pacchetti, Ilaria;
Bolli, Geremia B.

Publication type:

Article

Issue Information.

Published in:: Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 175, doi. 10.1111/dom.14426
Publication type:: Article